Home

Randomization Counter

 

----

 

 

 

What is the ISCHEMIA Study? 

  • An international comparative effectiveness study
  • The purpose of ISCHEMIA is to determine the best way to manage stable ischemic heart disease
  • Patients with moderate or severe ischemia on stress test imaging may be eligible for participation

If you are a physician and would like more information, please visit the For Physicians section. If you are a patient and would like to learn more about the ISCHEMIA study, please e-mail ischemia@nyumc.org 

Why is the ISCHEMIA Study Important?

Ischemic heart disease (IHD) is the leading cause of death and disability worldwide and affects 17,600,000 Americans, resulting in about 450,000 deaths in the United States annually. Globally, 7.2 million deaths are caused by IHD each year.

Medical therapy (medication and lifestyle changes) should always be used to treat IHD. Many doctors routinely use an invasive approach in addition to medical therapy to treat IHD; however, it is not known if this approach is better than medical therapy alone as the initial treatment of patients with stable ischemic heart disease (SIHD). ISCHEMIA is designed to find the answer. Click here to learn more about the ISCHEMIA study.

ISCHEMIA Enrollment Updates

ISCHEMIA Enrollment Updates

As of December 6th 2016, there are 3,643 participants (pts) randomized worldwide in the ISCHEMIA study. Click here to see the randomizations by country.

Congratulations To Our Top Sites!

Site name Region Study Team Rand Rate & Total Rands
Government Medical College  India PI: Dr. Sajeev, Dr. Rajesh & Dr. Kumar SC: Anand & Bijith

152 pts,
4.1 pts/mth

Northwick Park Hospital-Royal Brompton Hospital, London UK PI: Prof. Senior SC: Kinsey, Collins, Gurunathan, Hassan, Howard, Kavalakkat & Evans

150 pts,
3.4 pts/mth

Coronary and Structural Heart Diseases Department, Insitute of Cardiology Poland PI: Prof. Demkow SC: Chojnacka, Freleck & Pracon

105 pts,
2.3 pts/mth

Heart Insituto do Coracao- University of Sao Paulo Brazil PI: Dr. Hueb SC: Takiuti & Borges Miyamoto Girardi

97 pts,
3.5 pts/mth

Sri Jayadeva Institute of Cardiovascular Sciences and Research India PI: Dr. Manjunath & Dr. Moorthy SC: Nataraj & Murthy 97 pts,
2.7 pts/mth
Atlanta V.A. Medical Center USA PI: Dr. Mavromatis SC: Montazeri, Lee & Patel 95 pts,
2.5 pts/mth
Hospital Universitario La Paz Spain PI: Dr. Lopez Sendon SC: Valbuena, Castro, La Paz Mediavilla, Valbuena & Fernandez-Figar  89 pts,
2.3 pts/mth
Bakulev Scientific Center for Cardiovascular Surgery Russia Dr. L. Bockeria SC: O. Bockeria, & Kudzoeva  83pts,
2.1pts/mth
Ram Manohar Lohia Hospital India PI: Dr. Pandit SC: Bajaj, Pandit & Yadav  69 pts,
1.8 pts/mth
Montreal Heart Institute Canada PI: Gosselin SC: Vat & Proietti  66 pts,
1.3 pts/mth